NO

Naresh Otarmal Jain

Active Director Additional Director DIN 00366409
DIN 00366409 First appointment Jun 2005 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 10 active board seats
Past companies 7 historical roles
Total affiliations 17 Since Jun 2005
Shareholding value β€’β€’β€’β€’ Premium profile
Directorship timeline
First appointment 17 Jun 2005
Active appointments 10
Total timeline records 17

Naresh Otarmal Jain (DIN 00366409) has 17 recorded board appointments in Indian companies, the first from June 2005, of which 10 are current. The chart and the list below show each company, the role held and the years of the appointment, as filed with the Ministry of Corporate Affairs.

Appointment history

Since 2005
Medicef Pharma Limited Additional Director · 2026 – present
Current
Kalash Metals Private Limited Director · 2026 – present
Current
Jito Juhu Chapter Foundation Individual Subscriber · 2026 – present
Current
Micron Medica Private Limited Director · 2024 – present
Current
Current
Bhagyalaxmi Developers Private Limited Director · 2010 – present
Current
Current
Current
Micron Pharmaceuticals Limited Director · 2005 – present
Current
Crescent 3M Gymkhana Private Limited Director · 2005 – present
Current
Micro Orgo Chem Private Limited Director · 2011 – 2016
Previous
Maan Pharmaceuticals Ltd Additional Director · 2011 – 2013
Previous
Micron Biotech Limited Director · 2010 – 2016
Previous
Goodluck Marketing Private Limited Additional Director · 2010 – 2012
Previous
Aachen Resonance Private Limited Director · 2007 – 2016
Previous
Micro Crystal Housing Private Limited Director · 2007 – 2016
Previous
Citimake Builders Private Limited Director · 2005 – 2010
Previous

Interactive timeline

Hover bars for tenure details
Loading chart...
Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available